The chart is not accessible to screen readers. Please switch to the table view to access the data.
Advertisement
Advertisement
Leading 3 big pharma companies based on growth of share price in 2022
Leading global pharmaceutical risers based on share price 2022
This statistic displays the top three big pharmaceutical companies based on growth of share prices during 2022. Within that year, Eli Lilly's share price increased some ** percent. The other two top risers among big pharma companies were also from the U.S., Merck & Co. and AbbVie.
Log in or register to access precise data.
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Leading global mid and small biotech pharma risers based on share price 2022
- Premium Statistic Top global mid and small biotech pharma risers based on market cap growth 2022
- Premium Statistic Leading global pharmaceutical risers based on market capitalization 2022
- Premium Statistic Average value of biopharma M&A deals worldwide 2010-2019, by industry
- Premium Statistic Percentage return on R&D among large cap biopharma companies 2010-2020
- Basic Statistic 3 year average R&D cost to develop new biopharmaceutical compounds 2010-2020
- Premium Statistic Value of biopharma M&A deals worldwide 2010-2019, by industry
- Basic Statistic Members of EFPIA's pharmaceutical exports and imports 1990-2025
- Basic Statistic Projection of top therapeutic areas by sales worldwide 2019
- Basic Statistic R&D cost to develop new pharmaceutical compounds 2010-2020
About the region
10
- Premium Statistic Revenue forecast for global biologics market 2016-2022
- Premium Statistic Share of global immunoglobulin therapies market 2017, by country
- Basic Statistic Business metrics among biopharmaceutical companies by focus 2019
- Premium Statistic Orphan vs. non-orphan drugs median cost per patient per year 2014-2018
- Premium Statistic Cost to bring large cap biopharmaceutical assets to market 2010-2020
- Premium Statistic Key figures on established biotech centers worldwide 2012-2016
- Basic Statistic Amgen earnings per share 2004-2024
- Premium Statistic Count of first-time medtech approvals granted by FDA 2006-2017
- Premium Statistic Global biotechnology revenue by region 2012
- Basic Statistic Number of biopharma venture financing deals 2017-2022
Selected statistics
10
- Basic Statistic Number of biopharma M&A deals worldwide 2010-2019, by total transaction value
- Premium Statistic Number of biopharma M&A deals worldwide 2010-2019, by industry
- Premium Statistic Number of biopharma M&A deals worldwide 2010-2019, by companies
- Basic Statistic Projected top pharmaceutical companies based on new sales 2023
- Premium Statistic R&D spending growth worldwide on pharmaceuticals 2019-2032
- Basic Statistic Leading pharma and biotech companies in 2024, by net sales growth
- Premium Statistic Average peak sales forecast per new biopharmaceutical asset 2013-2025
- Basic Statistic Projected top pharmaceutical companies based on sales 2023
- Premium Statistic Average R&D cost to develop new biopharma compound 2013-2025
- Premium Statistic Top contract research organization transaction deals until 2023
Other regions
10
- Premium Statistic Market size of biopharmaceuticals in China 2013-20225
- Premium Statistic Market size of branded biopharmaceuticals in China 2013-2023
- Premium Statistic Pharma and biotech - average p/e ratios in 2005 and 2010
- Basic Statistic Revenue of top growing private specialty pharmacies in U.S. 2018
- Premium Statistic Pharmacy market sales' parallel import share - European countries 2024
- Premium Statistic Growth estimates for U.S. chemical drug and biologics markets 2014-2023
- Premium Statistic Market share of generics in Finland 2016-2021
- Premium Statistic Value of top U.S. biotech IPOs 2024
- Basic Statistic Revenue from top 20 women health products in the U.S. 2016
- Premium Statistic European public biotech companies - key figures 2012-2016
Related statistics
10
- Basic Statistic Global pharmaceutical industry by production value 2006-2018
- Premium Statistic Digital deals signed by top life sciences companies 2014-2018, by characteristics
- Premium Statistic Members of EFPIA's pharmaceutical market value 2000-2025
- Premium Statistic Total number of pharma merger and acquisition deals 2020-2024
- Premium Statistic Value of pharma and biotech merger and acquisition deals 2020-2024
- Basic Statistic Satisfaction or desire for received pharmaceutical services in the U.S. 2013
- Basic Statistic Top global orphan drugs by revenue 2018
- Basic Statistic Top five services from pharma companies for U.S. patients 2013
- Premium Statistic Veterinary vaccines market share worldwide in 2016, by technology
- Premium Statistic Pharmaceutical expenditure forecast worldwide by country 2030
Further Content: You might find this interesting as well
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Evaluate Vantage. (February 9, 2023). Leading 3 big pharma companies based on growth of share price in 2022 [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 31, 2026, from /statistics/347198/growth-top-pharmaceutical-and-biotech-companies-based-on-share-price/
Evaluate Vantage. "Leading 3 big pharma companies based on growth of share price in 2022." Chart. February 9, 2023. ÌÇÐÄÆƽâ°æ. Accessed July 31, 2026. /statistics/347198/growth-top-pharmaceutical-and-biotech-companies-based-on-share-price/
Evaluate Vantage. (2023). Leading 3 big pharma companies based on growth of share price in 2022. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 31, 2026. /statistics/347198/growth-top-pharmaceutical-and-biotech-companies-based-on-share-price/
Evaluate Vantage. "Leading 3 Big Pharma Companies Based on Growth of Share Price in 2022." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 9 Feb 2023, /statistics/347198/growth-top-pharmaceutical-and-biotech-companies-based-on-share-price/
Evaluate Vantage, Leading 3 big pharma companies based on growth of share price in 2022 ÌÇÐÄÆƽâ°æ, /statistics/347198/growth-top-pharmaceutical-and-biotech-companies-based-on-share-price/ (last visited July 31, 2026)
Leading 3 big pharma companies based on growth of share price in 2022 [Graph], Evaluate Vantage, February 9, 2023. [Online]. Available: /statistics/347198/growth-top-pharmaceutical-and-biotech-companies-based-on-share-price/
Advertisement